Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 23.03% ano a ano.
Alto Crescimento de Lucro
O lucro líquido da empresa lidera o setor, com o lucro anual mais recente totalizando US$ 5.10B.
Subavaliada
O PE mais recente da empresa é -26.97, em uma faixa percentil baixa de 3 anos.
Venda Institucional
As participações institucionais mais recentes são de 40.30M ações, uma redução de 38.29% em relação ao trimestre anterior.
Mantido por Larry Robbins
O Super Investidor Larry Robbins possui 1.93M ações desta empresa.